Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment. Neuro Oncol 2015 Nov;17(11):1538-9 PMID: 26361983 PMCID: PMC4648309

Author List

Boxerman JL, Schmainda KM, Zhang Z, Barboriak DP

Author

Kathleen M. Schmainda PhD Professor in the Radiology department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Angiogenesis Inhibitors
Brain Neoplasms
Cerebral Cortex
Female
Glioblastoma
Humans
Magnetic Resonance Imaging
Male



View this publication's entry at the Pubmed website PMID: 26361983
jenkins-FCD Prod-153 3ca6710ea990189ceb85f4312e7298b5922ce1a6